Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2620-2625

  Bredemeyer, Andrea L ^a   Huang, Ching Yu ^a   Walker, Laura M ^a   Bassing, Craig H ^b,c   Sleckman, Barry P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; KU ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA REPAIR; DNA STRAND BREAKAGE; GENE; GENE LOCUS; GENE REARRANGEMENT; GENETIC CODE; HOMOLOGOUS RECOMBINATION; HYBRID; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VDJ EXON; WILD TYPE; ANIMAL; ATAXIA TELANGIECTASIA; B LYMPHOCYTE; CELL CULTURE; CELL LINE; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENZYMOLOGY; GENETIC RECOMBINATION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; ATAXIA TELANGIECTASIA; B-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; GENE REARRANGEMENT, B-LYMPHOCYTE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 53149091313     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2620     Document Type: Article

References (30)

1. Tonegawa, S. 1983. Somatic generation of antibody diversity. Nature 302: 575-581.
2. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, and D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18: 495-527.
3. Rooney, S., J. Chaudhuri, and F. W. Alt. 2004. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol. Rev. 200: 115-131.
4. Buck, D., L. Malivert, R. de Chasseval, A. Barraud, M. C. Fondaneche, O. Sanal, A. Plebani, J. L. Stephan, M. Hufnagel, F. le Deist, et al. 2006. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124: 287-299.
5. Ahnesorg, P., P. Smith, and S. P. Jackson. 2006. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313.
6. Morzycka-Wroblewska, E., F. E. Lee, and S. V. Desiderio. 1988. Unusual immunoglobulin gene rearrangement leads to replacement of recombinational signal sequences. Science 242: 261-263.
7. Lewis, S. M., J. E. Hesse, K. Mizuuchi, and M. Gellert. 1988. Novel strand exchanges in V(D)J recombination. Cell 55: 1099-1107.
8. Bogue, M. A., C. Wang, C. Zhu, and D. B. Roth. 1997. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity 7: 37-47.
9. Bogue, M. A., C. Jhappan, and D. B. Roth. 1998. Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc. Natl. Acad. Sci. USA 95: 15559-15564.
10. Raghavan, S. C., J. Tong, and M. R. Lieber. 2006. Hybrid joint formation in human V(D)J recombination requires nonhomologous DNA end joining. DNA Repair 5: 278-285.
11. Sekiguchi, J. A., S. Whitlow, and F. W. Alt. 2001. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. Mol. Cell 8: 1383-1390.
12. Melek, M., M. Gellert, and D. C. van Gent. 1998. Rejoining of DNA by the RAG1 and RAG2 proteins. Science 280: 301-303.
13. Agrawal, A., Q. M. Eastman, and D. G. Schatz. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system (see comments). Nature 394: 744-751.
14. Verkaik, N. S., R. E. Esveldt-van Lange, D. van Heemst, H. T. Bruggenwirth, J. H. Hoeijmakers, M. Z. Zdzienicka, and D. C. van Gent. 2002. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur. J. Immunol. 32: 701-709.
15. Kabotyanski, E. B., L. Gomelsky, J. O. Han, T. D. Stamato, and D. B. Roth. 1998. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 26: 5333-5342.
16. Roth, D. B., and J. H. Wilson. 1986. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol. Cell. Biol. 6: 4295-4304.
17. Yan, C. T., C. Boboila, E. K. Souza, S. Franco, T. R. Hickernell, M. Murphy, S. Gumaste, M. Geyer, A. A. Zarrin, J. P. Manis, et al. 2007. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449: 478-482.
18. Corneo, B., R. L. Wendland, L. Deriano, X. Cui, I. A. Klein, S. Y. Wong, S. Arnal, A. J. Holub, G. R. Weller, B. A. Pancake, et al. 2007. Rag mutations reveal robust alternative end joining. Nature 449: 483-486.
19. Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3: 155-168.
20. Lavin, M. F., and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15: 177-202.
21. Huang, C. Y., G. G. Sharma, L. M. Walker, C. H. Bassing, T. K. Pandita, and B. P. Sleckman. 2007. Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes. J. Exp. Med. 204: 1371-1381.
22. Bredemeyer, A. L., G. G. Sharma, C. Y. Huang, B. A. Helmink, L. M. Walker, K. C. Khor, B. Nuskey, K. E. Sullivan, T. K. Pandita, C. H. Bassing, and B. P. Sleckman. 2006. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442: 466-470.
23. Vacchio, M. S., A. Olaru, F. Livak, and R. J. Hodes. 2007. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor α locus coding end breaks. Proc. Natl. Acad. Sci. USA 104: 6323-6328.
24. + thymocytes. Blood.
25. Muljo, S. A., and M. S. Schlissel. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat. Immunol. 4: 31-37.
26. Sekiguchi, J., D. O. Ferguson, H. T. Chen, E. M. Yang, J. Earle, K. Frank, S. Whitlow, Y. Gu, Y. Xu, A. Nussenzweig, and F. W. Alt. 2001. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proc. Natl. Acad. Sci. USA 98: 3243-3248.
27. Ma, Y., U. Pannicke, K. Schwarz, and M. R. Lieber. 2002. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108: 781-794.
28. Goodarzi, A. A., Y. Yu, E. Riballo, P. Douglas, S. A. Walker, R. Ye, C. Harer, C. Marchetti, N. Morrice, P. A. Jeggo, and S. P. Lees-Miller. 2006. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO J. 25: 3880-3889.
29. Han, J. O., S. B. Steen, and D. B. Roth. 1997. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol. Cell. Biol. 17: 2226-2234.
30. Han, J. O., L. A. Erskine, M. M. Purugganan, T. D. Stamato, and D. B. Roth. 1998. V(D)J recombination intermediates and non-standard products in XRCC4-deficient cells. Nucleic Acids Res. 26: 3769-3775.